|
|
Volumn 30, Issue 1, 2010, Pages
|
|
Update on the pharmacologic management of overactive bladder: the present and the future.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
MUSCARINIC RECEPTOR BLOCKING AGENT;
ARTICLE;
BEHAVIOR THERAPY;
COST OF ILLNESS;
DRUG APPROVAL;
EPIDEMIOLOGY;
FEMALE;
FORECASTING;
HEALTH;
HUMAN;
MALE;
METABOLISM;
OVERACTIVE BLADDER;
PATIENT COMPLIANCE;
PREVALENCE;
QUALITY OF LIFE;
UNITED STATES;
BEHAVIOR THERAPY;
CAUSALITY;
COST OF ILLNESS;
DRUG APPROVAL;
FEMALE;
FORECASTING;
HUMANS;
MALE;
MEDICATION ADHERENCE;
MUSCARINIC ANTAGONISTS;
PREVALENCE;
QUALITY OF LIFE;
UNITED STATES;
URINARY BLADDER, OVERACTIVE;
WORLD HEALTH;
MLCS;
MLOWN;
|
|
EID: 77952494692
PISSN: 1053816X
EISSN: None
Source Type: Journal
DOI: 10.7257/1053-816x.2010.30.1.29 Document Type: Article |
|
Times cited : (17)
|
|
References (0)
|
